Increased Risk for CVD Seen for Women With Premenstrual Disorders
By Elana Gotkine HealthDay Reporter

THURSDAY, July 17, 2025 -- Women with premenstrual disorders (PMDs) have an increased risk for cardiovascular diseases (CVDs), according to a study published online July 11 in Nature Cardiovascular Research.
Yihui Yang, M.P.H., from Karolinska Institutet in Stockholm, and colleagues used a Swedish nationwide population-based matched cohort study from 2001 to 2022 and a sibling matched cohort to examine whether women with PMDs have an increased risk for CVD. The population analysis included 99,411 women with PMDs, and the sibling analysis included 36,061 women with PMDs.
The researchers found that women with PMDs had a higher risk for any CVD compared with those without PMDs in the population analysis and the sibling analysis (adjusted hazard ratios, 1.11 and 1.10, respectively). For PMDs diagnosed before age 25 years and PMDs with comorbid perinatal depression, the risk was particularly pronounced.
"The increased risk was particularly clear in women who were diagnosed before the age of 25 and in those who had also experienced postnatal depression, a condition that can also be caused by hormonal fluctuations," Yang said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-18 06:00
Read more

- Everyday Packaging May Shed Tiny Plastics Into Your Food, Study Finds
- Weighted Vests Don't Protect Bone Health In Dieting Seniors, Trial Says
- Supreme Court Won’t Hear Anti-Vaccine Group’s Free Speech Case
- 'Pill-On-A-String' Could Revolutionize Testing For Throat Cancer
- Celltrion Announces U.S. FDA Approval of Additional Presentation of Steqeyma (ustekinumab-stba), Expanding Dosing Options for Pediatric Patients
- Severe Bleeding After Delivery Linked To Long-Term Heart Health Problems
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions